-
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
(PAR-19-258)
National Institute on Drug Abuse
Application Receipt Date(s): July 22, 2019; August 13, 2020, August 10, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
-
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
(PAR-19-259)
National Institute on Drug Abuse
Application Receipt Date(s): September 25, 2020; September 25, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
(PAR-19-260)
National Eye Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
(PAR-19-261)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): July 1, 2019, December 16, 2019, May 1, 2020, December 15, 2020, May 3, 2021, and December 13, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
(RFA-AR-20-001)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): August 5, 2019; December 2, 2019; April 1, 2020; August 3, 2020; December 1, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
(RFA-AR-20-002)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): August 5, 2019; December 2, 2019; April 1, 2020; August 3, 2020; December 1, 2020,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed)
(RFA-AR-20-003)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): July 10, 2019
-
"HEAL Initiative: Limited Competition: Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) to Reduce Opioid Prescribing (U24 Clinical Trial Not Allowed)"
(RFA-AT-19-011)
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): July 8, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed)
(RFA-DA-20-005)
National Institute on Drug Abuse
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional
(RFA-FD-19-016)
Food and Drug Administration
Application Receipt Date(s): June 25, 2019, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.